<DOC>
	<DOC>NCT01496053</DOC>
	<brief_summary>Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) in patients with ulcerative colitis (UC) and Crohn`s disease (CD), experience clinical, biochemical and genetical improvement in their disease. A prospective randomised study comparing the mushroom extract with placebo.</brief_summary>
	<brief_title>Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)</brief_title>
	<detailed_description />
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>moderate disease serious disease, biological treatment, pregnancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Cytokine levels in blood</keyword>
	<keyword>Calprotectin in feces</keyword>
	<keyword>Clinical symptom score.</keyword>
</DOC>